1. Company Directors - P
2. Price Ben Gil

Insider Trading History of Price Ben Gil

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Price Ben Gil since 2008. The trader's CIK number is 1417915. At the time of the last reporting, Price Ben Gil was the Director of Rexahn Pharmaceuticals, Inc.. (stock ticker symbol RNN). Also see all insider trading activities at Rexahn Pharmaceuticals, Inc..

Note that in the past Price Ben Gil also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Rexahn Pharmaceuticals, Inc. (RNN) by Price Ben Gil

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2019	RNN	15,000	$9,135	0	$0	0	$0

Yearly summary of insider trading at Sarepta Therapeutics, Inc. (SRPT) by Price Ben Gil

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	SRPT	4,500	$75,145	0	$0	0	$0
2013	SRPT	500	$15,587	0	$0	0	$0
2012	SRPT	30,000	$38,850	0	$0	0	$0
2011	SRPT	20,000	$30,000	0	$0	0	$0
2010	SRPT	51,000	$72,200	0	$0	0	$0
2009	SRPT	50,400	$33,038	0	$0	0	$0
2008	SRPT	6,582	$8,030	0	$0	0	$0

Insider trading activities at 2 companies by Price Ben Gil:

1. Rexahn Pharmaceuticals, Inc. (RNN)

2. Sarepta Therapeutics, Inc. (SRPT)

Table 1. Insider trading of Rexahn Pharmaceuticals, Inc. (RNN) by Price Ben Gil

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2019-01-29	RNN	Buy	15,000	.61	9,135

Table 2. Insider trading of Sarepta Therapeutics, Inc. (SRPT) by Price Ben Gil

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-03-14	SRPT	Buy	4,500	16.70	75,145
2013-08-19	SRPT	Buy	500	31.18	15,587
2012-03-14	AVII	Buy	30,000	1.29	38,850
2011-04-06	AVII	Buy	20,000	1.50	30,000
2010-08-13	AVII	Buy	4,000	1.93	7,720
2010-06-11	AVII	Buy	7,000	1.44	10,080
2010-05-13	AVII	Buy	40,000	1.36	54,400
2009-03-16	AVII	Buy	20,400	.67	13,688
2009-03-13	AVII	Buy	30,000	.65	19,350
2008-08-15	AVII	Buy	6,582	1.22	8,030

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Price Ben Gil (Director of Rexahn Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month